Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis : A real‐world study

enthalten in: Hepatology | 2022

von D’Alessio, A. | Fulgenzi, C. | Nishida, N. | +32

Reply

enthalten in: Hepatology | 2022

von D’Alessio, A. | Fulgenzi, C. | Pinato, D.

Reply

enthalten in: Hepatology | 2022

von D'Alessio, A. | Fulgenzi, C. | Pinato, D.

Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular Carcinoma

enthalten in: Hepatology | 2021

von Pinato, D. | Fessas, P. | Sapisochin, G. | +1

Retinoic Acid Receptor‐β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin‐Driven Activation and Durotaxis in Hepatic Stellate Cells

enthalten in: Hepatology | 2019

von Cortes, E. | Lachowski, D. | Rice, A. | +8

Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma

enthalten in: Hepatology | 2019

von Flynn, M. | Sayed, A. | Sharma, R. | +2

Breaking Kuhn's paradigm in advanced hepatocellular carcinoma

enthalten in: Hepatology | 2018

von Pinato, D.